Realta Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $42.6K | Sell |
514
-74
| -13% | -$6.14K | 0.02% | 237 |
|
2025
Q1 | $47.7K | Hold |
588
| – | – | 0.02% | 235 |
|
2024
Q4 | $54.3K | Sell |
588
-51
| -8% | -$4.71K | 0.02% | 247 |
|
2024
Q3 | $63.3K | Sell |
639
-3,488
| -85% | -$346K | 0.03% | 232 |
|
2024
Q2 | $383K | Sell |
4,127
-810
| -16% | -$75.1K | 0.07% | 272 |
|
2024
Q1 | $469K | Sell |
4,937
-330
| -6% | -$31.3K | 0.1% | 244 |
|
2023
Q4 | $470K | Sell |
5,267
-840
| -14% | -$75K | 0.11% | 227 |
|
2023
Q3 | $508K | Buy |
6,107
+100
| +2% | +$8.32K | 0.12% | 206 |
|
2023
Q2 | $500K | Sell |
6,007
-210
| -3% | -$17.5K | 0.11% | 220 |
|
2023
Q1 | $474K | Sell |
6,217
-2,255
| -27% | -$172K | 0.12% | 212 |
|
2022
Q4 | $703K | Hold |
8,472
| – | – | 0.17% | 138 |
|
2022
Q3 | $672K | Sell |
8,472
-963
| -10% | -$76.4K | 0.18% | 146 |
|
2022
Q2 | $722K | Buy |
9,435
+58
| +0.6% | +$4.44K | 0.18% | 133 |
|
2022
Q1 | $843K | Buy |
9,377
+4,245
| +83% | +$382K | 0.17% | 134 |
|
2021
Q4 | $575K | Buy |
5,132
+230
| +5% | +$25.8K | 0.13% | 190 |
|
2021
Q3 | $616K | Buy |
4,902
+50
| +1% | +$6.28K | 0.15% | 176 |
|
2021
Q2 | $657K | Sell |
4,852
-40
| -0.8% | -$5.42K | 0.16% | 164 |
|
2021
Q1 | $664K | Buy |
4,892
+21
| +0.4% | +$2.85K | 0.17% | 151 |
|
2020
Q4 | $686K | Buy |
4,871
+6
| +0.1% | +$845 | 0.19% | 121 |
|
2020
Q3 | $542K | Sell |
4,865
-135
| -3% | -$15K | 0.18% | 144 |
|
2020
Q2 | $560K | Buy |
5,000
+275
| +6% | +$30.8K | 0.18% | 139 |
|
2020
Q1 | $366K | Buy |
4,725
+641
| +16% | +$49.7K | 0.16% | 177 |
|
2019
Q4 | $383K | Buy |
4,084
+373
| +10% | +$35K | 0.1% | 224 |
|
2019
Q3 | $286K | Buy |
3,711
+470
| +15% | +$36.2K | 0.08% | 265 |
|
2019
Q2 | $286K | Buy |
3,241
+1,229
| +61% | +$108K | 0.08% | 265 |
|
2019
Q1 | $185K | Buy |
+2,012
| New | +$185K | 0.08% | 283 |
|